Impact of sustained virological response on prognosis after hepatectomy for hepatitis C-related hepatocellular carcinoma: a retrospective cohort study | Synapse
March 3, 2026Open Access
Impact of sustained virological response on prognosis after hepatectomy for hepatitis C-related hepatocellular carcinoma: a retrospective cohort study
Key Points
Survival rates improve significantly with sustained virological response after hepatectomy for hepatitis C-related liver cancer.
Patients who received direct-acting antiviral therapy (DAA) before surgery showed notably lower recurrence risks, making surgery outcomes more favorable.
In a retrospective cohort, various patient outcomes were analyzed following hepatectomy to see the impact of hepatitis C treatment.
Highlights the importance of HCV management in improving cancer surgery prognosis for liver cancer patients.
Abstract
Successful eradication of HCV via DAA therapy significantly enhances post-hepatectomy survival and mitigates recurrence risks.